Navigating Insulin-Based Therapy for Type 2 Diabetes

T2DM and CV Risk Program Image
Apply new studies on NPH, regular insulin, switching, and other approaches to avoid hypoglycemia, control hyperglycemia, and reduce CV risk with this module.
Veronica K. Piziak, MD, PhD, FACP
Program Director
Released: January 11, 2019 Expiration: No longer available for credit

Related Content

Expert commentary on the use of GLP-1 receptor agonists in the management of patients with type 2 diabetes

person default Arthi Thirumalai, MBBS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 18, 2020 Expired: December 17, 2021

CCO slides: patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk.

Anne Peters, MD Released: December 10, 2020

Get patient-specific guidance on T2D treatment options and insights on managing CVD and CKD risk, from Clinical Care Options (CCO)

Anne Peters, MD Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Released: December 10, 2020 Expired: December 9, 2021

Enter type 2 diabetes patient characteristics in this online CCO tool and compare your treatment plan with those of 5 experts

Martin J. Abrahamson, MD, FACP Zachary T. Bloomgarden, MD, MACE Anne Peters, MD Richard E. Pratley, MD Robert S. Zimmerman, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 9, 2020 Expired: December 8, 2021
Provided by Southern Medical Association
Southern Medical Association logo

Southern Medical Association, CME Division
3500 Blue Lake Drive, Suite 360
Birmingham, AL 35243
Tel: 800.423.4992, ext. 620
Email:  Education@sma.org
Website: http://sma.org

Supported by an educational grant from
Lilly USA, LLC

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue